Pages that link to "Q35035808"

The following pages link to Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects (Q35035808):

Displaying 39 items.

• 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats (Q24644922) (← links)
• The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
• Human cannabinoid pharmacokinetics (Q24652736) (← links)
• Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia (Q28285577) (← links)
• Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (Q28542740) (← links)
• Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (Q33869556) (← links)
• Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (Q34137084) (← links)
• Anxiogenic-like effects of chronic cannabidiol administration in rats (Q34232627) (← links)
• The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae). (Q34910131) (← links)
• Cannabidiol: a promising drug for neurodegenerative disorders? (Q34948216) (← links)
• The endocannabinoid system and its therapeutic exploitation (Q35876026) (← links)
• The safety of cannabinoids for the treatment of multiple sclerosis (Q36150541) (← links)
• Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus (Q36176491) (← links)
• Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine (Q36987924) (← links)
• Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines (Q37178591) (← links)
• A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (Q37235187) (← links)
• Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action (Q37285921) (← links)
• The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. (Q37892742) (← links)
• Cannabidiol in inflammatory bowel diseases: a brief overview (Q38027809) (← links)
• Anticipatory nausea in animal models: a review of potential novel therapeutic treatments (Q38208999) (← links)
• Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds (Q38785676) (← links)
• Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (Q39181416) (← links)
• An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol (Q39431492) (← links)
• Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid (Q41560604) (← links)
• Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy (Q41560648) (← links)
• Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. (Q46521805) (← links)
• Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury (Q46985556) (← links)
• Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells (Q47143965) (← links)
• Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats (Q48320014) (← links)
• Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats (Q48470514) (← links)
• Isomerization of cannabidiol and Δ9-tetrahydrocannabinol during positive electrospray ionization. In-source hydrogen/deuterium exchange experiments by flow injection hybrid quadrupole-time-of-flight mass spectrometry. (Q52888265) (← links)
• Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis. (Q54243217) (← links)
• Endocannabinoids and Schizophrenia. (Q55452539) (← links)
• Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability (Q89947802) (← links)
• Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria (Q90091572) (← links)
• Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms (Q91962253) (← links)
• Antioxidative and Anti-Inflammatory Properties of Cannabidiol (Q92282664) (← links)
• Immune Responses Regulated by Cannabidiol (Q93167508) (← links)
• The Essential Medicinal Chemistry of Cannabidiol (CBD) (Q98507441) (← links)